Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Marko Skelin

35476

Marko

Skelin

doc. dr. sc.

Naziv Uloga Akcije
Razvoj novog modela stručnog osposobljavanja studenata Farmacije Sveučilišta u Rijeci suradnik
Naziv Akcije
Skelin, Marko ; Šarčević, David ; Lešin Gaćina, Dina ; Mucalo, Iva ; Dilber, Ivo ; Javor, Eugen The effect of PARP inhibitors in homologous recombination proficient ovarian cancer: meta- analysis // Journal of chemotherapy, 34 (2023), 4; 1-8. doi: 10.1080/1120009X.2022.2073161
Dedić Plavetić, Natalija ; Dugonjić Okroša, Ana ; Silovski, Tajana ; Jović Zlatović, Josipa ; Jajac Bručić, Lana ; Skelin, Marko ; Mucalo, Iva Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy. // Journal of clinical oncology. 2023. doi: 10.1200/JCO.2023.41.16_suppl.560
Krečak, Ivan ; Pivac, Ljerka ; Lucijanić, Marko ; Skelin, Marko Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms // Biomedicines, 11 (2023), 5; 1301, 16. doi: 10.3390/biomedicines11051301
Krečak, Ivan ; Čeko, Monika ; Nižetić, Karla ; Čubrić, Eva ; Županović, Mediana ; Skelin, Marko ; Lucijanić, Marko Hematocrit to hemoglobin ratio (HHR) may improve prognostication in patients with pulmonary embolism // Scandinavian journal of clinical & laboratory investigation, 83 (2023), 3; 200-203. doi: 10.1080/00365513.2023.2191334
Jović Zlatović, J. ; Bevanda, M. ; Skelin, M. ; Telesmanić Dobrić, V. ; Curić, Z. ; Marijanović, I. ; Grubisić-Čabo, F. ; Krečak, I. ; Tomić, S. ; Kralik, K. et al. P-206 Association between primary tumor site of colorectal cancer and RAS/BRAF mutational status with venous thromboembolism: A retrospective- prospective cohort study from 3 Croatian oncology centers // Annals of oncology. 2022. str. S322-S323 doi: 10.1016/j.annonc.2022.04.296
Starčević, Dora ; Pranić, Shelly ; Pinjatela, Jerolima ; Skelin, Marko ; Mudnić, Ivana ANTIBIOTIC THERAPY IN THE COVID-19 PANDEMIC: RETROSPECTIVE COHORT STUDY OF PATIENTS HOSPITALIZED AT THE UNIVERSITY HOSPITAL OF SPLIT // Final programme and abstracts from the 10th Croatian Congress of Pharmacology and the 1st Croatian Congress of Clinical Pharmacology with International Participation. 2022. str. 224-224
Krečak, Ivan ; Nižetić, Karla ; Čeko, Monika ; Skelin, Marko ; Lucijanić, Marko Higher estimated plasma volume status may be associated with an inferior survival in patients with pulmonary embolism // International journal of laboratory hematology, 45 (2022), 2; e32-e35. doi: 10.1111/ijlh.13982
Krečak, Ivan ; Babić, Gordan ; Skelin, Marko Scurvy // Acta Dermatovenerologica Croatica, 30 (2022), 1; 59-60
Dedić Plavetić, Nataša; Dugonjić Okroša, Ana; Silovski, Tajana; Jović Zlatović, Josipa; Jajac Bručić, Lana; Skelin, Marko; Mucalo, Iva Influence of ovarian function supression on quality of life in breast cancer survivors on adjuvant endocrine therapy // 15th Croatian Oncology Congress - Book of Abstracts. Opatija: Central European Oncology Congress, 2022. str. /-/
Krečak, Ivan ; Celić-Bunikić, Sandra ; Skelin, Marko ; Lucijanić, Marko ; Verstovsek, Srdan ; Kušec, Rajko Concomitant multiple sclerosis and polycythemia vera successfully treated with glatiramer acetate // Annals of hematology, 101 (2022), 8; 1885-1886. doi: 10.1007/s00277-022-04839-2
nije evidentirano
nije evidentirano